PCR for flu surveillance

Historically, influenza outbreaks have been tracked by clinical findings and serology, and characterized by culture. In a study published in the latest issue of the British Medical Journal, Carman and colleagues compared the relative speed and sensitivity of three flu surveillance assays: serology, culture and polymerase chain reaction (PCR). Samples were collected from the nose and throat of 168 patients within a mean 5.3 days after the onset of flu symptoms; 112 patients were subsequently con

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Historically, influenza outbreaks have been tracked by clinical findings and serology, and characterized by culture. In a study published in the latest issue of the British Medical Journal, Carman and colleagues compared the relative speed and sensitivity of three flu surveillance assays: serology, culture and polymerase chain reaction (PCR). Samples were collected from the nose and throat of 168 patients within a mean 5.3 days after the onset of flu symptoms; 112 patients were subsequently confirmed to have flu infection. The fastest laboratory results were obtained by PCR (36 hours), followed by culture (minimum, 1 week) and serology (minimum, 3 weeks). In 60% of patients with positive serology and negative PCR results, samples had been collected 8 or more days after the onset of symptoms. PCR did not yield any false-positive results. For samples collected within 7 days of the onset of symptoms, the sensitivity of PCR for any positive ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform